Table 1.
Overview of included studies*
Authors | Year | Journal | Procedure Date Range | Ligament | Patients enrolled (A/S) | Study Design | Country | Mean Length of Follow up (Range) months | % Follow‐up | Male/Female | Age,y, Mean (Range) (A/S) |
---|---|---|---|---|---|---|---|---|---|---|---|
Nau15 | 2002 | JBJS | 1996–1998 | ACL | 27/26 | RCT | USA | 24 | 96.23 | 36/17 | 30.87 ± 8.66/31.03 ± 8.98 |
Fan16 | 2008 | CJRRS | 2002–2005 | ACL | 27/15 | Cohort | China | 26.3(2243)/24.1(18–40) | 100 | 34/8 | 20–52/17–40 |
Li17 | 2009 | SICOT | 2002–2006 | PCL | 15/21 | RCT | China | 28.8/26.4 | 100 | 30/6 | 20–43/18–47 |
Liu18 | 2010 | SICOT | 2003–2004 | ACL | 32/28 | Cohort | China | 49 (48–52) | 100 | 45/15 | 32 (20–56)/36 (18–54) |
Li 19 | 2012 | EJOST | 2007–2011 | ACL | 26/24 | RCT | China | 30 | 100 | 38/12 | 30.6(18–50)/32.6(18–50) |
Pan20 | 2013 | AOTS | 2004–2006 | ACL | 30/32 | Cohort | China | >48 | 100 | 44/18 | 33.93 ± 6.34/35.88 ± 11.30 |
Xu21 | 2014 | AOTS | 2006–2008 | PCL | 16/19 | Cohort | China | 51(46–57) | 100 | 17/18 | 29.1 ± 5.7/ 28.6 ± 6.8 |
Hamido2 | 2015 | OTSR | 2007–2008 | ACL | 45/27 | Cohort | Kuwait | 59(58–62) | 100 | 71/1 | 20(18–31)/24(21–35) |
Chen22 | 2017 | AJSM | 2004–2007 | ACL | 73/38 | Cohort | China | 122.9 ± 11.8/120.8 ± 26.9 | 83 | 92/19 | 28.6 ± 8.8(17–52) /27.6 ± 9.3 (17–54) |
A/S, Autografts/Synthetics; ACL, anterior cruciate ligament; AJSM, The American Journal of Sports Medicine; AOTS, Arch Orthop Trauma Surg; CJRRS, Chinese Journal of Reparative and Reconstructive Surgery; EJOST, Eur J Orthop Surg Traumatol; JBJS, The journal of bone and joint surgery; OTSR, Orthopedics & Traumatology: Surgery & Research; PCL, posterior cruciate ligament; SICOT, International Orthopedics.